CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- 4 Grant or award Director acquired 51,679 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 47,689 shares at an average $3.75 ($178,752)
- 4 Planned sale Director sold 3,000 shares at $3.82 ($11,460)
- 4 Grant or award Chief Commercial Officer acquired 10,400 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 47,689 shares at an average $4.02 ($191,655)
- 4 Planned sale Director sold 3,000 shares at $4.28 ($12,840)
- 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at an average $4.44 ($148,135)
- 4 Planned sale Director sold 3,000 shares at $4.75 ($14,238)
- 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at an average $4.03 ($134,366)
- 4 Planned sale Director sold 10,000 shares at $3.99 ($39,900)
- 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at $4.09 ($136,465)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
- 4 Grant or award Director acquired 21,367 shares (grant or award)
Page 3 of 9 · 163 filings